886615-31-2 Usage
Uses
Used in Pharmaceutical Synthesis:
(3-Bromo-6-chloro-2-fluorophenyl)Methanol is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of novel drug candidates with potential therapeutic applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (3-Bromo-6-chloro-2-fluorophenyl)Methanol is utilized as a building block for the preparation of various organic compounds, facilitating the design and synthesis of new molecules with potential medicinal properties.
Used in Drug Discovery:
(3-Bromo-6-chloro-2-fluorophenyl)Methanol plays a significant role in drug discovery, where its unique structural features can be leveraged to create innovative compounds that address unmet medical needs.
It is important to handle (3-Bromo-6-chloro-2-fluorophenyl)Methanol with caution and adhere to proper safety protocols in its handling and storage to ensure the safety of researchers and the integrity of experiments.
Check Digit Verification of cas no
The CAS Registry Mumber 886615-31-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,6,1 and 5 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 886615-31:
(8*8)+(7*8)+(6*6)+(5*6)+(4*1)+(3*5)+(2*3)+(1*1)=212
212 % 10 = 2
So 886615-31-2 is a valid CAS Registry Number.
886615-31-2Relevant articles and documents
6-(Poly-substituted aryl)-4-aminopicolinates and their use as herbicides
-
Page/Page column 10, (2008/06/13)
4-Aminopicolinic acids having tri- and tetra-substituted aryl substituents in the 6-position, and their amine and acid derivatives, are potent herbicides demonstrating a broad spectrum of weed control.
CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1
-
Page/Page column 53, (2008/06/13)
The present invention discloses compounds of Formula I: (I) having 11beta -HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as the use of the Fomula I and compositions as medicaments to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, Syndrome X, and other conditions associated with hyperglycemia.